Carvacrol Alters Soluble Factors in HCT-116 and HT-29 Cell Lines.
Natural products are a popular insight for researchers to investigate promising anti-cancer agents since some of these substances have lesser adverse effects restricting the treatment than traditional chemotherapeutic agents. A well-known monoterpene Carvacrol, widely consumed in Mediterranean cuisine and related to lower risks of cancer, has efficient anti-cancer effects. However, the mechanism of action is yet to be discovered. So this study aims to illuminate a new perceptive in the role of this substance on colorectal cancer treatment, by the means of differences in a well-defined range of soluble factors. Carvacrol effect on both HT-29 and HCT-116 were evaluated on proliferation and the IC50 values calculated by the RTCA xCELLigence device. Then MAGPIX assay was performed to obtain the changes in soluble factors of the cell lines. The Multiplexing assay suggests some of these factors altered in favor of surviving and proliferation in aggressive cell line HCT-116 whereas they altered against these characters in HT-29, correlated with the increased IC50 concentration of HCT-116 in carvacrol treatment. Therefore, the current study indicates that differences in the levels of these soluble factors could modulate the anti-cancer effect related to carvacrol.